NantKwest, ImmunityBio Plan to Merge,

“With 13 clinical trials across multiple tumor types at Phase I to III and with the combined talent in research, clinical development and manufacturing, …, “With 13 clinical trials across multiple tumor types at Phase I to III and with the combined talent in research, clinical development and manufacturing, …, Read More

Scroll to Top